Elevated levels of serum sclerostin are linked to adverse cardiovascular outcomes in peritoneal dialysis patients
International Urology and Nephrology Jan 25, 2018
Gong L, et al. - In this prospective observational study including stable peritoneal dialysis (PD) patients, the correlation between elevated serum sclerostin levels and chronic kidney disease outcomes was studied. Findings suggested that high sclerostin levels may predict the onset of cardiovascular events (CVEs) and cardiovascular mortality among PD patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
